CJC-1295 without DAC (Modified GRF 1-29) is a 29-amino acid GHRH analogue with a short half-life (~30 min). Unlike the DAC version, it does not produce sustained GH elevation u2014 it amplifies a single natural pulse when co-administered with a GHRP like Ipamorelin. This combination is often described as the gold standard for physiological GH optimisation.
Overview
Reconstitution Table (2 mL mL BAC water u2192 2 mg)
| Compound | Dose | Draw (U-100) |
| CJC-1295 no DAC | 100 mcg | 1 Unit |
| Combined with Ipamorelin | 200u2013300 mcg Ipa + 100 mcg CJC | Draw in same syringe |
Reconstitute 2 mg with 2 mL BAC water u2192 1,000 mcg/mL. Can be combined in the same syringe with Ipamorelin. Administer 30u201360 min pre-bed.
Do not confuse with CJC-1295 with DAC (much longer half-life, different dosing schedule). Research use only.
Potential Benefits & Side Effects
Potential Benefits
- Synergistic GH pulse with GHRP combination
- Improved sleep architecture
- Body composition support
- Preserves pituitary signalling (vs exogenous HGH)
Possible Side Effects
- Water retention
- Headache (mild)
- Transient flushing
Storage Instructions
Lyophilized Powder
- Short-term (<3 months): Refrigerate at 2u00b0Cu20138u00b0C
- Long-term: Freeze at u221220u00b0C or lower
- Protect from light and moisture
- Allow vial to reach room temperature before opening
Reconstituted Solution
- Refrigerate at 2u00b0Cu20138u00b0C u2014 do not freeze
- Use within 28 days when reconstituted with BAC water
- Always use sterile technique when drawing doses
References
Ionescu M. et al. (2004)
Sustained supraphysiologic levels of GH after CJC-1295 administration
View SourceImportant Note
This protocol guide is for educational and research purposes only. It is not medical advice. Always consult a qualified healthcare professional before using any peptide compound.